DocMorris (ZRSEF) News Today $39.03 0.00 (0.00%) (As of 11/14/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period DocMorris accelerates Rx growthOctober 15, 2024 | markets.businessinsider.comDocMorris Finance B.V.SF-Wdl.-Anl. 2024(29) BondSeptember 28, 2024 | markets.businessinsider.comJD Health International Inc 06618September 19, 2024 | morningstar.comRedcare Pharmacy N.V.: Kürzung der Guidance bei DocMorris belastet Redcare; mwb research stuft auf KAUFENAugust 28, 2024 | finanznachrichten.deWARBURG RESEARCH stuft DocMorris auf 'Hold'August 28, 2024 | finanznachrichten.deDocMorris grows in the prescription business and invests incrementally in new Rx customersAugust 20, 2024 | markets.businessinsider.comDocMorris AG (ZRSEF) Q2 2024 Earnings Call TranscriptAugust 20, 2024 | seekingalpha.comDocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025May 23, 2024 | markets.businessinsider.comDocMorris AG: Daniel Wüest becomes new CFO at DocMorrisMay 8, 2024 | markets.businessinsider.comDocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription marketApril 16, 2024 | markets.businessinsider.comDocMorris AG (ZRSEF) Q4 2023 Earnings Call TranscriptMarch 23, 2024 | seekingalpha.comDocMorris AG reports FY results; initiates FY24 outlookMarch 21, 2024 | msn.comLeafly Holdings Inc LFLYMarch 6, 2024 | morningstar.comDocMorris AG ZREJanuary 16, 2024 | morningstar.comDocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer baseJanuary 16, 2024 | markets.businessinsider.comDocMorris AG DOCMJanuary 9, 2024 | morningstar.comDocMorris N.V.January 2, 2024 | wsj.comDocMorris AG ZRSEFDecember 17, 2023 | morningstar.comPineapple Inc PNPLDecember 8, 2023 | morningstar.comClicks Group Ltd ADR CLCGYNovember 11, 2023 | morningstar.comDocMorris AG GAAP EPS of CHF12.12, revenue of CHF462.9MAugust 17, 2023 | msn.comUmbenennung: Online-Apotheke Zur Rose Group wird zu Doc MorrisMay 12, 2023 | msn.comAnnual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)May 5, 2023 | markets.businessinsider.comZur Rose Group has successfully completed the sale of its Swiss business to MigrosMay 4, 2023 | markets.businessinsider.comZur Rose delays profitability break-even to 2024March 23, 2023 | news.yahoo.comZur Rose Shares Slump After Pushing Break-Even Target to 2024March 23, 2023 | marketwatch.comZur Rose Group: Ist das der Beginn einer Trendwende?February 8, 2023 | finanznachrichten.deZur Rose Group is upgraded by Deutsche Bank to a hold ratingFebruary 7, 2023 | msn.comCiti Upgrades Zur Rose Group AG to NeutralFebruary 7, 2023 | investing.comZur Rose Group verabschiedet sich vom Schweizer Markt - Aktie springt nach obenFebruary 3, 2023 | finanznachrichten.deZur Rose Group hands over successful Swiss business to Migros to focus on growth in GermanyFebruary 3, 2023 | markets.businessinsider.comZur Rose Group: Aktie reagiert mit Kurssprung auf Erhöhung der ErgebnisprognoseJanuary 19, 2023 | finanznachrichten.deOnline pharmacy Zur Rose improves 2022 core loss targetJanuary 19, 2023 | msn.comZur Rose Group: Revenue target 2022 achieved, EBITDA better than expectedJanuary 19, 2023 | markets.businessinsider.comROSEG.S - | Stock Price & Latest News | ReutersJanuary 14, 2023 | reuters.comAktuelle Empfehlungen zur ZUR ROSE AktieDecember 12, 2022 | finanznachrichten.deZur Rose Group takes next step towards profitability and further reduces complexity in GermanyNovember 24, 2022 | markets.businessinsider.comZur Rose Group announces preliminary result and extension of Tender OfferOctober 7, 2022 | uk.finance.yahoo.comZur Rose Group announces a tender offer for all of its CHF 115 million outstanding bonds due 2023September 23, 2022 | uk.news.yahoo.comZur Rose Group AG (ROSEG)September 8, 2022 | investing.comZur Rose Group AG 2022 Q2 - Results - Earnings Call PresentationAugust 19, 2022 | seekingalpha.comOnline drug retailer Zur Rose targets break-even in 2023August 18, 2022 | nasdaq.comROSEWOOD VIENNA OPENS TODAYAugust 2, 2022 | markets.businessinsider.comBetül Susamis Unaran leaves Zur Rose GroupMay 31, 2022 | markets.businessinsider.comZur Rose Group sees revenue perform as expected in the first quarter of 2022April 20, 2022 | markets.businessinsider.comZur Rose Group: Excellent starting position for e-prescriptions set up and ecosystem strategy successfully continuedMarch 24, 2022 | markets.businessinsider.comEurope E-Pharmacy Market to Reach $19.23 Billion in 2027. Zur Rose Group and Shop Apotheke Sweeping Away the New Players – AriztonFebruary 23, 2022 | finance.yahoo.comEQS-News: Zur Rose Group: steady growth in a volatile market environmentJanuary 20, 2022 | markets.businessinsider.comEQS-News: Zur Rose Group nominates Rongrong Hu as directorJanuary 10, 2022 | markets.businessinsider.comZur Rose Group AG Registered Shares (ZRSEF)December 16, 2021 | nasdaq.com Get DocMorris News Delivered to You Automatically Sign up to receive the latest news and ratings for ZRSEF and its competitors with MarketBeat's FREE daily newsletter. Email Address Musk Says ‘Dollar Will Be Worth Nothing…’ (Ad)Cash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Click here to reserve your seat at the Crypto Community Summit. ZRSEF Media Mentions By Week ZRSEF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZRSEF News Sentiment▼0.000.54▲Average Medical News Sentiment ZRSEF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZRSEF Articles This Week▼00▲ZRSEF Articles Average Week Get DocMorris News Delivered to You Automatically Sign up to receive the latest news and ratings for ZRSEF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALBHF News Today ALST News Today CLCGY News Today FFLWF News Today HITIF News Today HITID News Today IWINF News Today SAEYY News Today TSUSF News Today TGIFF News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ZRSEF) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Abandons USDStartling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – ...True Gold Republic | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredElon Musk has put himself in their crosshairsToday, I have another controversial prediction. One which I will take no pleasure in seeing come true. ...Porter & Company | SponsoredTrump Win = "Bull Trap"?Dan's research shows that the last time the market looked this way, not only did our economy suffer a large su...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocMorris AG Please log in to your account or sign up in order to add this asset to your watchlist. Share DocMorris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
